CDSCO UID MFG/IVD/2023/000020_be3deebeaf3c3bbca746363ba68cc1a1_fa5e492113939d89d989f98328feb573

SARS-CoV-2: Rapid Antigen Test

Koshbio Private Limited·Device Class Class C·India CDSCO
Registration details
UID
MFG/IVD/2023/000020_be3deebeaf3c3bbca746363ba68cc1a1_fa5e492113939d89d989f98328feb573
Device class
Class C
Approving authority
Sub Zonal Baddi
Product information
SARS-CoV-2: Rapid Antigen Test is a rapid immunoassay for the qualitative detection of antigen of corona virus (NA) in human nasopharyngeal swab specimen to an aid in the diagnosis of infection with corona virus (NA). For in-vitro diagnostic use only.
Other products from Koshbio Private Limited
Products from the same license holder (10 products)
Glucose & Protein urinary analytes test strips
Class B
Blood Pressure Monitoring Device
Class B
Glucose Test Kit
Class B
Typhoid Antibody test kits
Class B
Human Chorionic Gonadotropin test kits
Class B
Male Fertility Test
Class B
Glucose, Protein & pH urinary analytes test strips
Class B
Lyse reagents for differential counts
Class B
Rinse / Detergent / Cleaners reagents
Class B
Blood cell Diluents
Class B
About this record

SARS-CoV-2: Rapid Antigen Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000020_be3deebeaf3c3bbca746363ba68cc1a1_fa5e492113939d89d989f98328feb573. The license holder is Koshbio Private Limited, and it is classified as Device Class Class C. The approving authority is Sub Zonal Baddi.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.